Results 251 to 260 of about 180,278 (321)

Laser Processing in Halide Photovoltaic Cells

Battery Energy, EarlyView.
In this review, recent advancements in the modulation of state‐of‐the‐art halide perovskites through laser processing are carefully discussed. Three main aspects pertaining to optimizing halide perovskite solar cells are summarized, including the thermodynamics and dynamics of perovskite crystals, the interaction between perovskite and transport layers,
Chunpeng Song, Shenyi Deng, Shihui Lou, Xipeng Yin, Qiuju Liang, Jiangang Liu   +5 more
wiley   +1 more source

The transition between M1 and M2 macrophage phenotypes is associated with the disease status following CD19 CAR-T therapy for B cell lymphoma/leukemia. [PDF]

Cell Death Dis
Zhao L, Yan F, Tang D, Li W, An N, Ren C, Wang Y, Xu K, Zhao K.   +8 more
europepmc   +1 more source

Immunomodulatory agents and cell therapy for patients with type 1 diabetes. [PDF]

Arch Endocrinol Metab
Rodacki M, Silva KR, Araujo DB, Dantas JR, Ramos MEN, Zajdenverg L, Baptista LS.   +6 more
europepmc   +1 more source

TPM4 influences the initiation and progression of gastric cancer by modulating ferroptosis via SCD1. [PDF]

Clin Exp Med
Zhao LL, Liu YJ, Guo QJ, Yan N, Yang J, Han JQ, Xie XH, Luo YS.   +7 more
europepmc   +1 more source

Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities. [PDF]

Signal Transduct Target Ther
Reschke R, Enk AH, Hassel JC.
europepmc   +1 more source

Breaking barriers: Smart vaccine platforms for cancer immunomodulation

Cancer Communications, EarlyView.
Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need to explore alternative approaches such as cancer vaccines. Leveraging the immune system's natural ability to target and kill cancer cells holds great therapeutic potential ...
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholam, Neda Rostami, Stephen M. Hatfield, Farzaneh Namazifar, Shadi Abkhiz, Seyed Sadegh Eslami, Mahsa Ramezanpour, Mahsa Darestanifarahani, Igor Astsaturov, Sidi A. Bencherif    +11 more
wiley   +1 more source

Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer. [PDF]

BMC Cancer
Ren W, Yu Y, Wang T, Wang X, Su K, Wang Y, Tang W, Liu M, Zhang Y, Yang L, Diao H.   +10 more
europepmc   +1 more source

Blocking ITGA5 potentiates the efficacy of anti‐PD‐1 therapy on glioblastoma by remodeling tumor‐associated macrophages

Cancer Communications, EarlyView.
Abstract Background Glioblastoma (GBM) is largely refractory to antibodies against programmed cell death 1 (anti‐PD‐1) therapy. Fully understanding the cellular heterogeneity and immune adaptations in response to anti‐PD‐1 therapy is necessary to design more effective immunotherapies for GBM.
Rongrong Zhao, Ziwen Pan, Jiawei Qiu, Boyan Li, Yanhua Qi, Zijie Gao, Wei Qiu, Weijie Tang, Xiaofan Guo, Lin Deng, Gang Li, Hao Xue   +11 more
wiley   +1 more source

SIM2, associated with clinicopathologic features, promotes the malignant biological behaviors of endometrial carcinoma cells. [PDF]

BMC Cancer
Nie H, Chen Y.
europepmc   +1 more source

Immunosuppressive JAG2+ tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells

Cancer Communications, EarlyView.
Abstract Background Tumor‐associated neutrophils (TANs) play a critical role in modulating immune responses and exhibit significant heterogeneity. Our previous study demonstrated that jagged canonical Notch ligand 2 (JAG2)+ TANs were associated with an immunosuppressive microenvironment in high‐grade serous ovarian cancer (HGSOC), but the underlying ...
Chenyang Wang, Moran Yang, Yujing Zhong, Kankan Cao, Xueling Wang, Chen Zhang, Yiying Wang, Mengdi He, Jiaqi Lu, Guodong Zhang, Yan Huang, Haiou Liu   +11 more
wiley   +1 more source